Results 61 to 70 of about 13,146 (180)

THE COMPARISON OF AMITRIPTYLINE AND MIRTAZAPINE SIDE EFFECTS ON DEPRESSION TREATMENT

Psychiatry and Clinical Psychopharmacology, 2021
Objective: In this study, the efficacy of amitriptyline and mirtazapine on depression and anxiety concomitant with depression and their side effects were compared.
Ramazan Özcankaya, Abdurahman Acar
doaj  

Use of Dual Orexin Receptor Antagonists for Insomnia and the Risk of Falls and Fractures: A Systematic Review and Meta‐Analysis

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Falls are the leading cause of injury in older adults. Sedative‐hypnotic use is a known risk factor, but their use for insomnia continues to be common. Dual orexin receptor antagonists (DORAs) are a new, potentially safer class of medications for insomnia.
Arianna Paolone, Shehraz Riar, Shajjan Vejayavarnan, Alexandra Papaioannou, George Ioannidis, Justin Lee   +5 more
wiley   +1 more source

Pregestational Stress Representing a Maternal Depression Model and Prenatally Applied Antidepressant Mirtazapine Modulate Hippocampal Excitability in Offspring

Scientia Pharmaceutica
Maternal depression negatively affects the neurodevelopment of offspring, but its pharmacological treatment during gestation remains controversial. This study reports the consequences of maternal depression and/or prenatal antidepressant treatment with ...
Lucia Dubiel-Hoppanova, Alzbeta Filipova, Stanislava Bukatova, Katarina Ondacova, Matus Tomko, Bohumila Jurkovicova-Tarabova, Michal Dubovicky, Eliyahu Dremencov, Lubica Lacinova   +8 more
doaj   +1 more source

Narcolepsy and rapid eye movement sleep

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Since the first description of narcolepsy at the end of the 19th Century, great progress has been made. The disease is nowadays distinguished as narcolepsy type 1 and type 2. In the 1960s, the discovery of rapid eye movement sleep at sleep onset led to improved understanding of core sleep‐related disease symptoms of the disease (excessive ...
Francesco Biscarini, Lucie Barateau, Fabio Pizza, Giuseppe Plazzi, Yves Dauvilliers   +4 more
wiley   +1 more source

Mirtazapine for the Treatment of Chronic Pruritus

Medicines, 2019
Background: Chronic pruritus is a debilitating condition associated with a wide range of dermatologic, systemic and psychogenic etiologies. In patients with chronic pruritus that is refractory to conventional therapy, symptoms can significantly decrease ...
Raveena Khanna, Emily Boozalis, Micah Belzberg, John G. Zampella, Shawn G. Kwatra   +4 more
doaj   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont, Vanessa Bloch, Agnès Lillo‐Lelouet, Christine Le Beller, Pierre A. Geoffroy, Marc Veyrier   +5 more
wiley   +1 more source

Low-dose Mirtazapine Induced Hyponatraemia with Probable Syndrome of Inappropriate Antidiuretic Hormone Secretion in an Elderly Male: A Case Report [PDF]

Journal of Clinical and Diagnostic Research
Hyponatraemia is a common and potentially serious condition in elderly patients. It is associated with significant morbidity including delirium, falls and prolonged hospitalisation.
Vakshi, Suverna Jyothi Kantipudi, Akkash Kumar Ravichandran, Chamelee Anbu, Sushma Vishwanathan   +4 more
doaj   +1 more source

Daridorexant‐ Case Report of Possible Side‐Effect in Rare Mitochondrial Disorder

Journal of Sleep Research, EarlyView.
ABSTRACT This case report describes a 40‐year‐old woman with maternally inherited diabetes and deafness (MIDD), a rare mitochondrial disorder, who received treatment with daridorexant due to severe chronic insomnia. She developed progression of her MIDD symptoms during treatment.
Sven Svedmyr, Joel Bergqvist
wiley   +1 more source

Long‐Term Outcome of Electrochemotherapy in the Treatment of Advanced Stages (T3–T4) of Feline Nasal Planum Squamous Cell Carcinoma

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT Electrochemotherapy is increasingly used as a locoregional treatment for feline squamous cell carcinoma, but its role in advanced nasal planum disease remains poorly defined. This retrospective study evaluated the long‐term outcome of ECT as a sole treatment modality in 18 cats with T3–T4N0M0 nasal planum squamous cell carcinoma.
Delia Franchini, Ilaria Laino, Chiara Perrone, Antonio Di Bello, Stefano Ciccarelli   +4 more
wiley   +1 more source

Infection with the Neorickettsial Organism Stellantchasmus falcatus Agent in an Arctic Fox (Vulpes lagopus)

Veterinary Clinical Pathology, EarlyView.
ABSTRACT A 1‐year‐old female‐intact arctic fox (Vulpes lagopus) presented for diarrhea, lethargy, severe thrombocytopenia, and hyperbilirubinemia. Blood film evaluation revealed intracytoplasmic coccoid bacteria within moderate numbers of leukocytes consistent with infection by a rickettsial organism.
Jeremy P. Bessett, Alexis G. Davidson, Alyssa M. Scagnelli, Kristen R. Friedrichs   +3 more
wiley   +1 more source